{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:24:40Z","timestamp":1787030680214,"version":"build-2736575974"},"reference-count":48,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.3892\/ol.2017.6246","type":"journal-article","created":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T06:39:14Z","timestamp":1495607954000},"page":"569-578","source":"Crossref","is-referenced-by-count":16,"title":["99mTc-LHRH in tumor receptor imaging"],"prefix":"10.3892","volume":"14","author":[{"given":"Dawei","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,5,24]]},"reference":[{"key":"key20180108115651_b1-ol-0-0-6246","first-page":"367","article-title":"Research progress of relation between GnRH and its receptor and tumors","volume":"8","author":"Yuan","year":"2002","journal-title":"Prog Anatomical Sci"},{"key":"key20180108115651_b2-ol-0-0-6246","first-page":"179","article-title":"Application of gonadotropin-releasing hormone and its receptor in cancer therapy","volume":"36","author":"Jia","year":"2009","journal-title":"J Int Pharm Res"},{"key":"key20180108115651_b3-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0024-3205(98)00173-8","article-title":"Expression of the messenger RNA for gonadotropin-releasing hormone and its receptor in human cancer cell lines","volume":"62","author":"Yin","year":"1998","journal-title":"Life Sci"},{"key":"key20180108115651_b4-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1210\/en.2007-1502","article-title":"Functional characterization of genetically labeled gonadotropes","volume":"149","author":"Wen","year":"2008","journal-title":"Endocrinology"},{"key":"key20180108115651_b5-ol-0-0-6246","first-page":"315","article-title":"The current development and prospect of tumor molecular nuclear medicine","volume":"24","author":"Xie","year":"2009","journal-title":"Kawakita medical report"},{"key":"key20180108115651_b6-ol-0-0-6246","first-page":"241","article-title":"Immunohistochemical and in situ hybridization study of thyroid gonadotropin-releasing hormone receptor in rats","volume":"11","author":"Ji","year":"2002","journal-title":"Chinese J Histochem Cytochem"},{"key":"key20180108115651_b7-ol-0-0-6246","first-page":"5439","article-title":"High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines","volume":"53","author":"Emons","year":"1993","journal-title":"Cancer Res"},{"key":"key20180108115651_b8-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1021\/bc800058k","article-title":"Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency","volume":"19","author":"Schottelius","year":"2008","journal-title":"Bioconjug Chem"},{"key":"key20180108115651_b9-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"149S","DOI":"10.2967\/jnumed.107.045963","article-title":"Tumor receptor imaging","volume":"49","author":"Mankoff","year":"2008","journal-title":"J Nucl Med"},{"key":"key20180108115651_b10-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1210\/endo.142.6.8190","article-title":"Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase","volume":"142","author":"Gr\u00fcndker","year":"2001","journal-title":"Endocrinology"},{"key":"key20180108115651_b11-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1200\/JCO.2010.32.5704","article-title":"Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study","volume":"29","author":"Gerber","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20180108115651_b12-ol-0-0-6246","first-page":"1458","article-title":"High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines","volume":"77","author":"Emons","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180108115651_b13-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.clinthera.2006.10.018","article-title":"Luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer: a review of their discovery, development, and place in therapy","volume":"28","author":"Moreau","year":"2006","journal-title":"Clin Ther"},{"key":"key20180108115651_b14-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"52500","DOI":"10.1074\/jbc.M404571200","article-title":"The luteinizing hormone-releasing hormone inhibits the anti-apoptotic activity of insulin-like growth factor-1 in pituitary alphaT3 cells by protein kinase C alpha-mediated negative regulation of Akt","volume":"279","author":"Rose","year":"2004","journal-title":"J Biol Chem"},{"key":"key20180108115651_b15-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1002\/1097-0142(19900515)65:10<2279::AID-CNCR2820651020>3.0.CO;2-3","article-title":"Inhibitory effects of analogs of luteinizing hormone-releasing hormone and somatostatin on pancreatic cancers in hamsters. Events that accompany tumor regression","volume":"65","author":"Szende","year":"1990","journal-title":"Cancer"},{"key":"key20180108115651_b16-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.addr.2009.05.006","article-title":"Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines","volume":"61","author":"Greco","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"key20180108115651_b17-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrc1958","article-title":"Polymer conjugates as anticancer nanomedicines","volume":"6","author":"Duncan","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"key20180108115651_b18-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1210\/jcem-64-3-425","article-title":"Gonadotropin-releasing hormone (GnRH)-binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonists","volume":"64","author":"Eidne","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180108115651_b19-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.nucmedbio.2004.05.003","article-title":"Backbone metal cyclization: novel 99mTc labeled GnRH analog as potential SPECT molecular imaging agent in cancer","volume":"31","author":"Barda","year":"2004","journal-title":"Nucl Med Biol"},{"key":"key20180108115651_b20-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1186\/1471-2407-14-847","article-title":"Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125","volume":"14","author":"Seitz","year":"2014","journal-title":"BMC Cancer"},{"key":"key20180108115651_b21-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cdp.2005.07.004","article-title":"Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status","volume":"29","author":"Rusiecki","year":"2005","journal-title":"Cancer Detect Prev"},{"key":"key20180108115651_b22-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1200\/JCO.2004.10.216","article-title":"Receptor imaging in oncology by means of nuclear medicine: current status","volume":"22","author":"Van Den Bossche","year":"2004","journal-title":"J Clin Oncol"},{"key":"key20180108115651_b23-ol-0-0-6246","first-page":"97","article-title":"Fas and Fas ligand system may mediate antiproliferative activity of gonadotropin-releasing hormone receptor in endometrial cancer cells","volume":"13","author":"Imai","year":"1998","journal-title":"Int J Oncol"},{"key":"key20180108115651_b24-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.2741\/2386","article-title":"Multimodality imaging of vascular endothelial growth factor and vascular endothelial growth factor receptor expression","volume":"12","author":"Cai","year":"2007","journal-title":"Front Biosci"},{"key":"key20180108115651_b25-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.2174\/1381612023393756","article-title":"Experience with indium-111 and yttrium-90-labeled somatostatin analogs","volume":"8","author":"Virgolini","year":"2002","journal-title":"Curs Pharm Des"},{"key":"key20180108115651_b26-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0039-6060(96)80043-2","article-title":"Evaluation of somatostatin-receptor scintigraphy for detecting neuroendocrine tumors","volume":"120","author":"Meko","year":"1996","journal-title":"Surgery"},{"key":"key20180108115651_b27-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nm878","article-title":"Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"9","author":"Katsuno","year":"2003","journal-title":"Nat Med"},{"key":"key20180108115651_b28-ol-0-0-6246","first-page":"224","article-title":"Somatostatin receptor scintigraphy in small-cell lung cancer: results of a multicenter study","volume":"39","author":"Reisinger","year":"1998","journal-title":"J Nucl Med"},{"key":"key20180108115651_b29-ol-0-0-6246","first-page":"107","article-title":"99mTc-labeled vasoactive intestinal peptide analog for rapid localization of tumors in humans","volume":"41","author":"Thakur","year":"2000","journal-title":"J Nucl Med"},{"key":"key20180108115651_b30-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00006676-198910000-00001","article-title":"Membrane receptors for peptides in experimental and human pancreatic cancers","volume":"4","author":"Fekete","year":"1989","journal-title":"Pancreas"},{"key":"key20180108115651_b31-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ijc.2910540220","article-title":"Effect of bombesin, gastrin-releasing peptide (GRP)(14\u201327) and bombesin\/GRP receptor antagonist RC-3095 on growth of nitrosamine-induced pancreatic cancers in hamsters","volume":"54","author":"Szepeshazi","year":"1993","journal-title":"Int J Cancer"},{"key":"key20180108115651_b32-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1740-8261.2005.00031.x","article-title":"A review of small animal imaging planar and pinhole spect Gamma camera imaging","volume":"46","author":"Peremans","year":"2005","journal-title":"Vet Radiol Ultrasound"},{"key":"key20180108115651_b33-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00202070","article-title":"Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors","volume":"74","author":"Friess","year":"1996","journal-title":"J Mol Med (Berl)"},{"key":"key20180108115651_b34-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1021\/bc800058k","article-title":"Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency","volume":"19","author":"Schottelius","year":"2008","journal-title":"Bioconjug Chem"},{"key":"key20180108115651_b35-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.2967\/jnumed.108.053041","article-title":"Peptide-based probes for cancer imaging","volume":"49","author":"Reubi","year":"2008","journal-title":"J Nucl Med"},{"key":"key20180108115651_b36-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4067\/S0716-97602002000100004","article-title":"Glucose transporters: expression, regulation and cancer","volume":"35","author":"Medina","year":"2002","journal-title":"Biol Res"},{"key":"key20180108115651_b37-ol-0-0-6246","first-page":"40","article-title":"Clinical outlook for radio-immunity imaging","volume":"13","author":"Wang","year":"1989","journal-title":"Int J Radiat Med Nucl Med Volume"},{"key":"key20180108115651_b38-ol-0-0-6246","first-page":"396","article-title":"Clinical application of radioimmunoimaging with 99mTc-BDI-1 in the diagnosis of bladder cancer","volume":"113","author":"Wang","year":"2000","journal-title":"Chin Med J (Engl)"},{"key":"key20180108115651_b39-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/108497803321269313","article-title":"A review of the intravenous administration of radiolabeled immunoglobulin G to cancer patients. High or low protein dose?","volume":"l8","author":"Vriesendorp","year":"2003","journal-title":"Cancer Biother Radiopharm"},{"key":"key20180108115651_b40-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"164S","DOI":"10.2967\/jnumed.107.045955","article-title":"Molecular-genetic imaging based on reporter gene expression","volume":"49","author":"Kang","year":"2008","journal-title":"J Nucl Med"},{"key":"key20180108115651_b41-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"113S","DOI":"10.2967\/jnumed.107.045922","article-title":"Multimodality molecular imaging of tumor angiogenesis","volume":"49","author":"Cai","year":"2008","journal-title":"J Nucl Med"},{"key":"key20180108115651_b42-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/1097-0215(20010601)92:5<628::AID-IJC1244>3.0.CO;2-L","article-title":"[177Lu-DOTA0,Tyr3]octreotate for somatostatin receptor-targeted radionuclide therapy","volume":"92","author":"de Jong","year":"2001","journal-title":"Int J Cancer"},{"key":"key20180108115651_b43-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00259-002-1025-9","article-title":"11C-metomidate PET imaging of adrenocortical cancer","volume":"30","author":"Khan","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"key20180108115651_b44-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s10350-008-9420-3","article-title":"Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study","volume":"51","author":"Dietz","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"key20180108115651_b45-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"117l","DOI":"10.1016\/S0360-3016(00)01433-4","article-title":"A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy","volume":"49","author":"Chao","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180108115651_b46-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0360-3016(02)04477-2","article-title":"Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report","volume":"55","author":"Dehdashti","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180108115651_b47-ol-0-0-6246","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF02988451","article-title":"Monitoring of response to radiation therapy for human tumor xenografts using 99mTc-HL91 (4,9-diaza-3,3,10,10-tetramethyldodecan-2,11-dione dioxime)","volume":"17","author":"Suzuki","year":"2003","journal-title":"Ann Nucl Med"},{"key":"key20180108115651_b48-ol-0-0-6246","first-page":"92","article-title":"Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with 99mTc-Annexin V","volume":"44","author":"Mochizuki","year":"2003","journal-title":"J Nucl Med"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T14:38:33Z","timestamp":1515422313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2017.6246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,24]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,5,24]]},"published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.3892\/ol.2017.6246"],"URL":"https:\/\/doi.org\/10.3892\/ol.2017.6246","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,24]]}}}